QUANTRX BIOMEDICAL CORP Quarterly Debt-to-equity in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Quantrx Biomedical Corp quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2022.
  • Quantrx Biomedical Corp Debt-to-equity for the quarter ending September 30, 2022 was -100 %, a 1.32% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 -100 +1.34 +1.32% Sep 30, 2022
Q2 2022 -100 +1.65 +1.62% Jun 30, 2022
Q1 2022 -101 +2.94 +2.84% Mar 31, 2022
Q4 2021 -101 +3.31 +3.17% Dec 31, 2021
Q3 2021 -102 +3.84 +3.64% Sep 30, 2021
Q2 2021 -102 +7.6 +6.93% Jun 30, 2021
Q1 2021 -104 +10.2 +8.95% Mar 31, 2021
Q4 2020 -104 +16.2 +13.4% Dec 31, 2020
Q3 2020 -105 +23.7 +18.4% Sep 30, 2020
Q2 2020 -110 +36.1 +24.8% Jun 30, 2020
Q1 2020 -114 +53 +31.8% Mar 31, 2020
Q4 2019 -121 +75.9 +38.7% Dec 31, 2019
Q3 2019 -129 +110 +46% Sep 30, 2019
Q2 2019 -146 +44.7 +23.5% Jun 30, 2019
Q1 2019 -167 -8.65 -5.47% Mar 31, 2019
Q4 2018 -196 -64 -48.4% Dec 31, 2018
Q3 2018 -239 -127 -113% Sep 30, 2018
Q2 2018 -190 -76.8 -67.7% Jun 30, 2018
Q1 2018 -158 -43.2 -37.6% Mar 31, 2018
Q4 2017 -132 -15.6 -13.4% Dec 31, 2017
Q3 2017 -112 +6.86 +5.75% Sep 30, 2017
Q2 2017 -114 +9.35 +7.61% Jun 30, 2017
Q1 2017 -115 +12.4 +9.72% Mar 31, 2017
Q4 2016 -117 +13.5 +10.3% Dec 31, 2016
Q3 2016 -119 +14.8 +11% Sep 30, 2016
Q2 2016 -123 +17.2 +12.3% Jun 30, 2016
Q1 2016 -127 +14.3 +10.1% Mar 31, 2016
Q4 2015 -130 +17 +11.6% Dec 31, 2015
Q3 2015 -134 +17.7 +11.7% Sep 30, 2015
Q2 2015 -140 +15.4 +9.93% Jun 30, 2015
Q1 2015 -142 +26.5 +15.8% Mar 31, 2015
Q4 2014 -147 +34.3 +18.9% Dec 31, 2014
Q3 2014 -152 +47.8 +24% Sep 30, 2014
Q2 2014 -155 +81.6 +34.4% Jun 30, 2014
Q1 2014 -168 +130 +43.6% Mar 31, 2014
Q4 2013 -182 +271 +59.9% Dec 31, 2013
Q3 2013 -200 +1.89K +90.5% Sep 30, 2013
Q2 2013 -237 -1.05K -129% Jun 30, 2013
Q1 2013 -298 -575 -207% Mar 31, 2013
Q4 2012 -453 Dec 31, 2012
Q3 2012 -2.09K Sep 30, 2012
Q2 2012 815 Jun 30, 2012
Q1 2012 277 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.